Log in to save to my catalogue

Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted...

Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fa19b5e281b4cd58808c1584714e112

Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies

About this item

Full title

Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies

Publisher

England: BioMed Central Ltd

Journal title

Journal of nanobiotechnology, 2023-11, Vol.21 (1), p.454-22, Article 454

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

As a naturally occurring cytolytic peptide, melittin (MLT) not only exhibits a potent direct tumor cell-killing effect but also possesses various immunomodulatory functions. MLT shows minimal chances for developing resistance and has been recognized as a promising broad-spectrum antitumor drug because of this unique dual mechanism of action. Howeve...

Alternative Titles

Full title

Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_5fa19b5e281b4cd58808c1584714e112

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5fa19b5e281b4cd58808c1584714e112

Other Identifiers

ISSN

1477-3155

E-ISSN

1477-3155

DOI

10.1186/s12951-023-02223-4

How to access this item